Medication Management System Market: Strong Pipeline to Rapidly Surge Growth

The global Medication Management System Market is likely to display a CAGR of 11% while garnering US$ 7.1 Billion during the forecast period of 2022-2032. Growth of the market can be attributed to the increasing investment by hospitals to enhance workflow and rapid development in medical technology.

As per the WHO report 2017, globally, medication error costs about US$ 42 Billion annually. This has resulted in increased demand for medication management systems as a vital part of overall healthcare infrastructure. As per another report by WHO, by 2020, about 73% of global deaths would be from chronic illness like cardiovascular diseases, and cancer, which demands long-term medication with proper medication dispensing and continuous patient monitoring, which can be performed efficiently through the medication management system.

The deployment of advanced technologies in medication management is projected to augment the market size in the forecast period. For instance, in August 2019, Pharmazam launched personalized real-time medication management and the healthcare system. Pharmazam's Pharmacogenetic (PGx) test results consist of a comprehensive DNA test and a sample that is collected using an FDA-cleared device. Such factors are expected to benefit the market during the forecast period.

Increasing demand for reducing human errors in medication management, growing demand for quality care, and growing adoption rate in emerging economies are the most vital factors that are expected to boost the expansion of the clinical support segment solutions in the coming time. However, heavy expenses associated with the installation, maintenance, and operations are expected to hinder the market in the coming time. Also, lack of expertise in a computerized program and reluctance to adopt modern techniques among evolving economies are other vital factors that can restrain industry growth in the forecast period.

Key Takeaways from the Study:

  • The global medication management system market is expected to hold a value worth US$ 2.5 Billion in 2022.
  • From 2017-21, the global medication management system market is projected to have displayed a CAGR of 10.8%.
  • In 2022, the medication management system market in North America is anticipated to secure 52% of global revenue.
  • In 2022, the medication management system market in Europe is expected to claim 23% of the global revenue.

Competition Analysis

Key players in the global medication management system market include Omnicell, Inc., Cerner Corporation, McKesson Corporation, Medication Management Systems, Inc., Talyst, GE Healthcare, Becton, Dickinson and Company, and Allscripts.

Recent Updates from the Market Include:

  • In December 2021, Omnicell, Inc. a known provider of medication management solutions and adherence tools for health systems and pharmacies, announced it has inked an agreement with ReCept Holdings, Inc., The agreement aims to acquire its business for total aggregate cash consideration of $100 million, subject to customary adjustments. The acquisition will broaden Omnicell's portfolio of capabilities and services to address the significant need to improve access to and care coordination for complex medications.
  • In July 2022, BD (Becton, Dickinson and Company) announced it has completed the acquisition of Parata Systems. Parata advances BD's transformative solutions strategy by offering a portfolio of innovative pharmacy automation solutions that power a growing network of pharmacies to lessen costs, increase patient safety and enhance the patient experience for retail.

Get More Details@ https://www.futuremarketinsights.com/reports/medication-management-system-market

Comments

Post a Comment

Popular posts from this blog

Empowering Diabetics | A Comprehensive Analysis of the Continuous Glucose Monitoring Device Market

Image
According to Future Market Insights' recently released Continuous Glucose Monitoring Device Market Analysis report, global sales of Continuous Glucose Monitoring Device Market in 2022 will be US$ 4.9 Billion. The market is expected to be valued US$ 16.8 billion by 2033, with a CAGR of 11.9% from 2023 to 2033. Market growth is predicted to be driven by an increase in the older population as well as a high prevalence of diabetes. The International Diabetes Federation predicts that the global diabetic population will reach 642 million by 2040. As a result, by 2040, one out of every 10 people would have diabetes, demonstrating the seriousness of the epidemic. Diabetes treatment and management are consequently projected to be a top priority for healthcare administrations and stakeholders around the world. Diabetes cases are predicted to increase, boosting market growth and the potential for continuous glucose monitoring systems, attracting and motivating various industry actors to prod...
Read more

Global Medical face shield Market Insights and Outlook 2022-2032

Image
Medical face shield can become as ubiquitous as masks, as new findings on the airborne spread of Covid-19 influence behavior and guidelines. According to a latest study by Future Market Insights,  Medical Face Shields Market  will grow at over 11% CAGR through 2030. Medical face shields have proven to be an effective first-line defence against airborne diseases such as Zika, SARS, Ebola, flu, and now Covid-19. As a result, increased adoption of medical face shields, and thus increased production, is expected to drive the market during the forecast period. The IDSA (Infectious Diseases Society of America) has included the use of PPE (Personal Protective Equipment) such as face shields and masks in its recommendations. Though masks have been widely used throughout the world, their effectiveness is not widely known. The possibility of cloth masks providing marginal virus protection due to potential moisture retention, poor filtration, and re-use cannot be ruled out. Face ...
Read more

Cognitive Diagnostics Market Projected to Reach Unprecedented Growth by 2033

Image
As per Future Market Insights latest industry analysis, the valuation for the global  Cognitive Diagnostics market sales  is estimated to reach US$ 110.2 Billion in 2023 and is projected to exhibit a CAGR of 8.0% over the forecast period, with an estimated valuation of US$ 238.3 Billion by 2033. Several causes of brain problems or cognitive disorders include closed head injuries, contact with neurotoxins (toxic substances), genetics, infections, strokes, and tumours. Depending on the area of the brain that is impacted, a person may have a certain form of cognitive problem. Communication issues could result from, for instance, a tumour in the speech cisterns of the brain. In another illustration, a brain infection that affects the motor recentres would cause problems with movement. Ageing is also a factor in the development of cognitive problems. Cognitive diagnostics increasingly use digital health technologies like wearables and smartphone apps. These tools can monitor a pati...
Read more